청피로부터 추출한 항암, 항염증 치료제 및 HJ001의추출방법
    1.
    发明公开
    청피로부터 추출한 항암, 항염증 치료제 및 HJ001의추출방법 无效
    抗生素治疗药物,CITRUS RETICULATA BLANCO提取的抗炎药和HJ001提取方法

    公开(公告)号:KR1020070117373A

    公开(公告)日:2007-12-12

    申请号:KR1020060051571

    申请日:2006-06-08

    CPC classification number: A61K36/752 A61K2236/39 Y10S514/886

    Abstract: A therapeutic agent HJ001 isolated from Citrus reticulata Blanco is provided to inhibit growth of cancer cells and reduce expressions of IL-3(interleukin-3), IL-6, IL-12p40p70, IL-12p70 and SCF(stem cell factor) and increase expressions of IL-10 and TNF(tumor necrosis factor), so that it is useful for treatment of cancer and inflammatory disease. A method for preparing the extract of Citrus reticulata Blanco HJ001 comprises the steps of: dipping Citrus reticulata Blanco powder in water and filtering the solution; passing the filtered solution through the column packed with fillers HP-20 and collecting passed solution; mixing the collected solution with water-saturated ethylacetate to transfer it into an ethylacetate layer; inducing layer separation of the mixture into the ethylacetate layer and water layer, and separating the water layer; mixing the water layer with water-saturated butanol and separating a butanol layer; absorbing the butanol layer to TLC(thin layer chromatography) silica; subjecting the TLC silica by using chloroform, methanol and water as development solvent and separating the developed portion; dissolving the developed portion in butanol, and filtering and concentrating the solution; freeze-drying the filtered solution to obtain materials Fr1 and Fr2; and separating the Fr2 from the Fr1 and Fr2.

    Abstract translation: 提供从柑橘网布兰科分离的治疗剂HJ001,以抑制癌细胞的生长并降低IL-3(白细胞介素-3),IL-6,IL-12p40p70,IL-12p70和SCF(干细胞因子)的表达并增加 IL-10和TNF(肿瘤坏死因子)的表达,因此可用于治疗癌症和炎性疾病。 柑橘柑橘提取物Blanco HJ001的制备方法,包括:将柑橘网Blanco粉浸入水中过滤溶液; 将过滤的溶液通过填充有填料HP-20的柱并收集通过的溶液; 将收集的溶液与水饱和的乙酸乙酯混合以将其转移到乙酸乙酯层中; 诱导层将混合物分离成乙酸乙酯层和水层,并分离水层; 将水层与水饱和的丁醇混合并分离丁醇层; 将丁醇层吸收至TLC(薄层色谱法)二氧化硅; 用氯仿,甲醇和水作为显影溶剂对TLC二氧化硅进行处理,分离显影部分; 将显影部分溶解在丁醇中,过滤并浓缩溶液; 冷冻干燥过滤溶液以获得材料Fr1和Fr2; 并将Fr2与Fr1和Fr2分离开。

Patent Agency Ranking